180 Life Sciences P/E
Quel est le P/E de 180 Life Sciences?
Le P/E de 180 Life Sciences Corp. est 0.53
Quelle est la définition de P/E?
Le ratio cours / bénéfice est le rapport entre le prix des actions d'une entreprise et le bénéfice par action de l'entreprise calculé sur les douze derniers mois.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E des entreprises dans Health Care secteur sur NASDAQ par rapport à 180 Life Sciences
Que fait 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Entreprises avec p/e similaire à 180 Life Sciences
- QuantumScape a P/E de 0.52
- Eastnine AB (publ) a P/E de 0.52
- CNFinance Ltd a P/E de 0.52
- China Metal Resources Utilization a P/E de 0.52
- Datametrex AI a P/E de 0.52
- Warehouses De Pauw NV a P/E de 0.53
- 180 Life Sciences a P/E de 0.53
- Salzgitter AG a P/E de 0.53
- Euromedis e a P/E de 0.53
- Star Equity a P/E de 0.54
- AMTD IDEA a P/E de 0.55
- Prairie Provident Resources a P/E de 0.55
- Brighthouse a P/E de 0.55